QDEL Stock Cash Flow Statements

Quidel Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Quidel Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31

operating activities:
net income	479,936,000	291,317,000	215,752,000	19,073,000	178,084,000	470,130,000	232,268,000	67,652,000	40,237,000	30,626,000	16,181,000	1,270,000	24,844,000	32,479,000	10,822,000	-3,076,000	33,958,000	-5,088,000	-5,525,000	-11,842,000	14,290,000	-1,950,000	-572,000			-377,000	-762,000	-8,931,000	3,991,000	7,113,000	-5,767,000	-6,908,000	-1,512,000	1,139,000	-4,361,000	-1,755,000	12,367,000	8,740,000	-676,000	-3,122,000	51,000	958,000	-1,113,000	-3,660,000	11,448,000	-426,000	-5,861,000	-2,467,000	-2,517,000	20,107,000	14,940,000	-1,712,000	4,817,000
adjustments to reconcile net income to net cash from operating activities:
depreciation, amortization and other	16,782,000	14,401,000	12,792,000	14,486,000	12,705,000	12,308,000	12,415,000	11,886,000	12,480,000	15,051,000	12,282,000	12,487,000	11,971,000	11,943,000	10,704,000	11,544,000	12,075,000	12,949,000	6,236,000	5,887,000	5,690,000	5,199,000	5,187,000	6,287,000	6,123,000	5,849,000	5,717,000	5,618,000	6,202,000	7,787,000	6,885,000	6,361,000	7,332,000	6,237,000	6,334,000	5,067,000	7,056,000	6,776,000	5,623,000	5,282,000	5,580,000	5,746,000	5,298,000	3,386,000	3,379,000	3,547,000	3,324,000	3,246,000	2,209,000	1,888,000	1,612,000
stock-based compensation expense	7,432,000	6,727,000	7,005,000	5,846,000	5,828,000	6,458,000	5,553,000	5,130,000	3,878,000	3,168,000	3,124,000	3,372,000	3,588,000	2,519,000	2,775,000	3,479,000	2,936,000	3,123,000	1,879,000	2,138,000	1,921,000	2,166,000	1,734,000	2,106,000	1,980,000	1,706,000	1,719,000	1,926,000	2,068,000	1,952,000	1,293,000	1,242,000	2,237,000	3,324,000	1,419,000	1,887,000	2,141,000	1,597,000	1,406,000	1,732,000	1,863,000	2,347,000	1,468,000	1,914,000	1,771,000	1,277,000	1,256,000	1,415,000	1,210,000	2,020,000	787,000	1,162,000	1,259,000	3,395,465	968	934	633
amortization of deferred financing costs	101,000
accretion of interest on deferred consideration	982,000	970,000	957,000	1,107,000	1,451,000	1,543,000	1,414,000	1,717,000	1,895,000	1,872,000	1,848,000	2,161,000	2,343,000	2,314,000	2,285,000	2,608,000	2,793,000
net change in operating lease right-of-use assets and liabilities	9,351,000	370,000	861,000	987,000	794,000
change in deferred tax assets and liabilities	-89,000	23,905,000	157,000	165,000	446,000	-19,770,000	-420,000	-99,000	78,000									264,000	348,000			4,772,000	-157,000	-4,589,000	-2,629,000	2,341,000	-3,937,000	-3,716,000	1,285,000	6,497,000	-5,682,000			-5,378,000	87,000	2,426,000	937,000	3,861,000	-713,000	-1,680,000	1,000	-1,310,000	-1,006,000	-2,352,000	5,885,000
changes in assets and liabilities:
accounts receivable	-191,452,000	-42,683,000	-289,559,000	24,042,000	427,052,000	-143,878,000	-241,766,000	-8,713,000	-7,737,000	-16,715,000	-33,341,000	24,679,000	-10,682,000	7,979,000	-22,085,000	47,547,000	-25,205,000	-25,470,000	-21,738,000	1,108,000	4,048,000	1,199,000	-9,958,000	10,213,000	-7,719,000	12,619,000	-15,325,000	2,984,000	15,782,000	-10,011,000	-7,224,000	-564,000	13,252,000	-10,289,000	-6,013,000	751,000	18,462,000	-15,438,000	-4,351,000	1,666,000	199,000	2,659,000	-6,435,000	5,340,000	-2,733,000	-615,000	-2,627,000	2,768,000	3,553,000	15,711,000	-16,620,000	3,237,000	6,660,000		-9,136	7,330	2,322
inventories	17,355,000	-1,706,000	21,463,000	-43,662,000	-61,134,000	-17,954,000	-2,448,000	-33,899,000	-602,000	3,748,000	2,691,000	2,022,000	682,000	-4,129,000	-3,555,000	-1,761,000	5,471,000	-2,389,000	-465,000	-360,000	3,576,000	-2,685,000	-274,000	1,682,000	2,136,000	-1,823,000	-886,000	286,000	786,000	-1,253,000	1,000	1,459,000	2,655,000	-275,000	-2,572,000	-3,902,000	-5,226,000	1,065,000	319,000	-907,000	-1,552,000	197,000	385,000	-402,000	2,873,000	1,556,000	655,000	602,000	-393,000	-2,155,000	-994,000		678,000				431
prepaid expenses and other current and non-current assets	-7,291,000	1,972,000	4,699,000	-6,116,000	-13,811,000	-9,184,000	-1,289,000	-4,112,000	321,000	-628,000	2,803,000	-1,856,000	3,995,000	845,000	-2,001,000	-6,586,000	-4,939,000	-8,446,000	1,241,000	-368,000	-1,540,000	495,000	-132,000	271,000	-1,186,000	-734,000	60,000	92,000	-457,000	1,152,000	-1,021,000	2,095,000	-1,439,000	3,588,000	-3,943,000	1,995,000	-504,000				-1,731,000
accounts payable	52,592,000	13,907,000	6,663,000	-6,264,000	-3,860,000	32,665,000	10,147,000	2,775,000	6,639,000	-1,995,000	5,237,000	-2,610,000	1,802,000	-964,000	5,703,000	-4,475,000	-595,000	10,828,000	6,192,000	253,000	-4,317,000	3,339,000	2,926,000	-3,092,000	1,150,000	-1,135,000	1,780,000	-531,000	-3,196,000	5,160,000	585,000	-769,000	-596,000	191,000	1,117,000	648,000	-2,607,000	2,422,000	-310,000	-1,799,000	1,232,000	415,000	952,000	-1,262,000	21,000	-141,000	-993,000	1,043,000	-2,504,000	53,000	2,574,000
accrued payroll and related expenses	-10,944,000	8,874,000	12,221,000	-70,000	-16,054,000	5,946,000	5,104,000	7,834,000	-2,860,000	4,743,000	-1,743,000	2,932,000	-6,969,000	1,698,000	1,481,000	4,483,000	-5,988,000	6,148,000	345,000	2,130,000	-1,493,000	1,492,000	-341,000	1,764,000	-3,290,000	289,000	1,403,000	239,000	-870,000	841,000	1,219,000	-254,000	-559,000	419,000	1,621,000	-668,000	-317,000	1,243,000	909,000	180,000	-1,249,000	-1,436,000	1,118,000	-92,000	1,727,000	-947,000	-320,000	-737,000	-632,000	472,000	1,275,000
income taxes payable	138,384,000	1,015,000	58,307,000	-167,396,000	41,386,000	85,894,000													40,000	-1,761,000	1,799,000	60,000	-10,000	165,000	-167,000	-793,000	940,000	-209,000	-2,000	-1,155,000	-63,000
other current and non-current liabilities	-12,167,000	2,092,000	25,640,000	-12,267,000	12,469,000	13,826,000	-12,903,000	6,678,000	6,634,000	8,203,000	2,888,000	-5,846,000	721,000	1,223,000	4,110,000	-2,913,000	2,323,000	2,891,000	2,793,000	-953,000	2,173,000	557,000	-304,000	-2,244,000	7,000	-2,312,000	1,953,000	-6,683,000	5,956,000	-736,000	4,289,000	-2,996,000	745,000	3,683,000	-1,397,000	-2,936,000	509,000	3,647,000	1,662,000	-850,000	-1,656,000	-593,000	958,000	21,000	-458,000	-780,000	512,000	-1,328,000	-3,040,000	-1,251,000	7,642,000
net cash from operating activities:	500,972,000		77,059,000	-178,024,000	585,457,000		70,455,000	58,997,000	61,180,000		13,330,000	40,534,000	32,897,000		6,666,000	50,648,000	35,814,000		-7,523,000	-5,568,000	29,575,000		-2,350,000
investing activities:
acquisitions of property, equipment, investments and intangibles	-22,402,000	-32,325,000
proceeds from government assistance allocated to fixed assets		0	13,618,000	9,541,000	13,722,000
purchases of marketable securities	-15,937,000																																																	985,000
proceeds from sale of marketable securities	13,669,000																																													0	0	0	3,999,000
net cash from investing activities:	-24,670,000		-93,245,000	-65,704,000	-64,569,000		-22,724,000	-7,504,000	-5,884,000		-6,932,000	-6,791,000	-4,993,000		-9,298,000	-8,628,000	141,695,000		-4,430,000	-19,013,000	-3,712,000		-2,403,000
financing activities:
proceeds from issuance of common stock	3,527,000	240,000	2,444,000	493,000	4,373,000	789,000	2,733,000	3,286,000	2,805,000	1,626,000	4,923,000	1,386,000	6,847,000	1,016,000	6,482,000	3,897,000	5,652,000	10,180,000	9,981,000	2,200,000	3,065,000	3,754,000	2,723,000	544,000	1,554,000		1,332,000	224,000	596,000		2,127,000	537,000	1,839,000		1,346,000																498,000
payments on finance lease obligation	-91,000	-67,000	-65,000	-66,000	-62,000	-158,000	-125,000	-116,000	-112,000	-109,000	-105,000	-119,000	-38,000
payments of tax withholdings related to vesting of stock-based awards	-6,815,000	-1,136,000	-614,000	-1,467,000	-33,929,000
principal payments of acquisition contingent consideration	-29,000		-10,000
net cash from financing activities:	-3,408,000		1,756,000	-144,321,000	-29,648,000		-43,201,000	-87,724,000	705,000		-5,957,000	-62,147,000	-14,679,000		2,476,000	-105,154,000	-111,796,000		9,890,000	2,126,000	2,121,000		2,546,000
effect of exchange rates on cash	-109,000		-347,000	221,000	-129,000		428,000	50,000	-6,000		-81,000	20,000	18,000		175,000	-3,000	13,000		9,000	9,000	2,000		3,000	2,000	-12,000		0	-12,000	-9,000		-29,000
net increase in cash and cash equivalents	472,785,000	224,304,000	-14,777,000	-387,828,000	491,111,000	412,394,000	4,958,000	-36,181,000	55,995,000	23,861,000	360,000	-28,384,000	13,243,000	5,001,000	19,000	-63,137,000	65,726,000		-2,054,000	-22,446,000	27,986,000			2,120,000	-38,024,000	8,911,000	-22,175,000	-24,694,000	28,534,000	183,530,000	-710,000	-7,085,000	16,772,000			-22,426,000	29,519,000	-2,986,000	-2,037,000	-1,676,000	-39,777,000	10,287,000	-14,251,000	6,358,000	52,150,000	-441,000				28,655,000	10,915,000	-2,087,000	2,355,000			-742	4,873				7,571
cash and cash equivalents, beginning of period	802,751,000	0	0	0	489,941,000	0	0	0	52,775,000	0	0	0	43,695,000	0	0	0	36,086,000	0	0	0	169,508,000	0	0	0	191,471,000	0	0	0	200,895,000	0	0	0	8,388,000	0	0	0	14,856,000		0	0	61,332,000		0	0	6,788,000		0	0	89,003,000		0	0	36,625,000		0	0	34,930		0	0	36,322
cash and cash equivalents, end of period	1,275,536,000		-14,777,000	-387,828,000	981,052,000		4,958,000	-36,181,000	108,770,000		360,000	-28,384,000	56,938,000		19,000	-63,137,000	101,812,000		-2,054,000	-22,446,000	197,494,000		-2,204,000	2,120,000	153,447,000		-22,175,000	-24,694,000	229,429,000		-710,000	-7,085,000	25,160,000		-11,701,000	-22,426,000	44,375,000		-2,037,000	-1,676,000	21,555,000		-14,251,000	6,358,000	58,938,000		-7,602,000	-5,432,000	20,263,000		10,915,000	-2,087,000	38,980,000		-8,467	-742	39,803		-2,750	-16,815	43,893
supplemental disclosures of non-cash investing and financing transactions:
purchase of property, equipment and intangibles by incurring current liabilities	13,714,000		-23,483,000	23,880,000	7,284,000		1,361,000
capital expenditures to be reimbursed under a government contract				997,000	12,622,000
reduction of other current liabilities upon issuance of restricted share units	2,850,000		0	0	2,001,000		0						1,970,000																408,000		0	0	663,000		0	9,000	447,000
operating activities
impairment loss										337,000																				0
amortization of debt discount and deferred issuance costs		100,000	101,000	101,000	101,000	156,000	182,000	216,000	217,000	215,000	216,000	549,000	602,000	597,000	641,000	1,043,000	1,671,000	1,893,000	1,388,000	1,376,000	1,365,000	1,625,000	1,412,000	1,425,000	1,429,000	1,432,000	1,422,000	1,411,000	1,399,000
change in fair value of acquisition contingencies		116,000	0			557,000	0			841,000	0			369,000	0							104,000								-952,000	0	0	42,000
change in fair value of derivative liabilities - convertible notes
payment of accreted interest on contingent and deferred consideration		0	0
loss on extinguishment of debt						0				0	0				1,297,000	2,398,000	4,567,000
net cash from operating activities																									-7,597,000	16,057,000	-3,010,000	-8,504,000	31,766,000	18,208,000	186,000	-4,865,000	22,157,000	1,464,000	-5,098,000	-5,129,000	34,445,000	13,748,000	1,619,000	1,480,000	2,786,000	13,111,000	142,000	8,093,000	25,636,000	3,097,000	667,000	-36,000	-14,021,000	45,089,000	15,864,000	2,415,000	16,083,000				5,776				7,810
capex																									0	-4,965,000	-4,655,000	-4,481,000	-2,867,000	-2,657,000	-1,873,000	-2,652,000	-3,967,000	-3,879,000	-5,194,000	-8,928,000	-2,820,000	-5,318,000	-2,918,000	-2,927,000	-1,058,000	-201,000	-1,348,000	-1,518,000	-1,438,000	-2,172,000	-2,980,000	0	-978,000	-3,670,000	-1,591,000	0	0				0				0
free cash flows																									-7,597,000	11,092,000	-7,665,000	-12,985,000	28,899,000	15,551,000	-1,687,000	-7,517,000	18,190,000	-2,415,000	-10,292,000	-14,057,000	31,625,000	8,430,000	-1,299,000	-1,447,000	1,728,000	12,910,000	-1,206,000	6,575,000	24,198,000	925,000	-2,313,000	-36,000	-14,999,000	41,419,000	14,273,000	2,415,000	16,083,000				5,776				7,810
investing activities
net cash from investing activities																									-7,095,000	-5,029,000	-4,655,000	-4,481,000	-2,867,000	-2,657,000	-1,873,000	-2,652,000	-4,059,000	-4,175,000	-7,720,000	-18,298,000	-3,742,000	-5,453,000	-4,112,000	-3,164,000	-15,871,000	-3,166,000	-14,637,000	-1,501,000	-1,483,000	-3,136,000	-4,759,000	-1,153,000	-125,491,000	-2,954,000	-6,628,000
financing activities
payments on revolving credit facility										-8,188,000	-10,000,000	-15,000,000	-20,000,000	-30,000,000	0	0	-10,000,000
repurchases of common stock		0	0			-657,000	-2,384,000	-42,894,000	-1,954,000	-8,828,000	-29,000	-395,000	-1,476,000	-554,000	-183,000	-375,000	-3,232,000	0	-53,000	-51,000	-437,000	-72,000	-17,000	0	-20,079,000	-3,317,000	-15,484,000	-11,796,000	-337,000	0	-5,000	0	-1,951,000	-1,166,000	-133,000	-297,000	-561,000				-3,387,000
payments on acquisition contingent consideration														-9,000	-3,277,000
payments of deferred consideration						0	0			0	0			0
payment on convertible note and derivative liability
transaction costs related to debt exchange										0				0			-1,357,000
net cash from financing activities																									-23,320,000	-2,121,000	-14,510,000	-11,697,000	-356,000	167,951,000	1,006,000	429,000	-1,326,000	856,000	1,117,000	1,001,000	-1,184,000	-11,281,000	456,000	8,000	-26,692,000	342,000	244,000	-234,000	27,997,000	-402,000	-3,510,000	-4,243,000	70,772,000	-13,480,000	1,679,000						164	5,123,470	1,922	1,383	225
effect of exchange rate changes on cash
cash and cash equivalents, at end of period
change in fair value of derivative liabilities - convertible senior notes						0	0
principal payments of deferred consideration			1,000
payment on convertible senior note and derivative liability						-30,000
extinguishment of convertible senior notes through issuance of stock
acquisitions of property, equipment and intangibles				-75,245,000	-78,291,000	-28,815,000	-22,724,000	-7,504,000	-5,884,000					-8,814,000	-9,298,000	-8,628,000	-4,949,000	-4,743,000	-4,697,000	-4,358,000	-3,712,000	-4,049,000	-2,436,000	-3,423,000	-2,001,000
initial measurement of derivative liabilities – convertible senior notes
payments of acquisition contingent consideration					-30,000		-9,000	-6,000,000	-34,000		-13,000	-4,019,000	-12,000
amortization of inventory step-up to fair value														0	0	0	3,650,000
proceeds from sale of summers ridge property														0	0	0	146,644,000
payments of debt issuance costs																										0	0	0	-365,000
payments of term loan														0
extinguishment of convertible senior notes through issuance of common stock							460,000
acquisitions of property, equipment
acquisition of other businesses, net of cash acquired
acquisition of triage and bnp businesses
proceeds from issuance of term loan
proceeds from issuance of revolving credit facility
payment of debt issuance costs
acquisitions of property and equipment												-6,791,000	-4,993,000													-4,965,000	-4,655,000	-4,481,000	-2,867,000	-2,657,000	-1,873,000	-2,652,000	-3,967,000	-3,879,000	-5,194,000	-8,928,000	-2,820,000	-5,318,000	-2,918,000	-2,927,000	-1,058,000	-201,000	-1,348,000	-1,518,000	-1,438,000	-2,172,000	-2,980,000
purchase of property and equipment by incurring current liabilities													1,728,000
non-cash financing activities:
gain on extinguishment of debt
payments on lease obligation														-37,000	-33,000	-31,000	-29,000	-28,000	-26,000	-23,000	-21,000	-107,000	-148,000	-144,000	-141,000	-134,000	-129,000	-125,000	-121,000	-115,000	-113,000	-108,000	-105,000	-100,000	-96,000	-93,000	-91,000	-87,000	-82,000	-82,000	-78,000	-73,000	-71,000	-69,000	-67,000	-52,000	-53,000	-52,000	-48,000
repurchases of convertible senior notes																						0	0	0	-4,459,000
income taxes receivable															-5,511,000	-4,388,000	3,097,000		-257,000	-2,929,000	2,063,000		-311,000	-56,000	119,000		632,000	-770,000	372,000		1,307,000
principal amount of term loan exchanged for revolving credit facility
payments on deferred consideration
payments on term loan																-60,000,000	-101,813,000
payments of debt transaction costs
payments on acquisition contingencies																	-1,017,000	1,000	-12,000	0	-486,000	0	-12,000	0	-195,000	0	0	0	-129,000	0	-1,003,000	0	-1,109,000
gain on extinguishment of convertible senior notes																						0	0	0	-421,000
restricted cash																						0	0	0	63,000	1,747,000	3,051,000	-1,396,000	-338,000	2,920,000
deferred grant revenue																						0	-961,000	-951,000	-1,746,000	-1,859,000	-777,000	1,176,000	-1,212,000	-1,583,000
payment for acquisition holdback																										0
net decrease in cash and cash equivalents																																																-5,432,000	-68,740,000
acquisition of businesses, net of cash acquired																			267,000
acquisition of immutopics, net of cash acquired																						0	33,000	0	-5,094,000
excess tax benefit from share-based compensation																																		-1,409,000	0	0	-937,000													-29,000
proceeds from issuance of convertible senior notes
net income:																									-3,446,000
acquisition of biohelix, net of cash acquired																																			-34,000
acquisition of andiatec
acquisition of intangibles																														0	0	0	-92,000		-221,000	-220,000	-922,000				-14,928,000
proceeds from issuance of common stock, net of cancellations																																					3,531,000								58,558,000	95,000	178,000	80,000	798,000
payments on line of credit																																		0	0	0	-5,000,000	-14,000,000	0	0	-23,000,000	0	0
supplemental disclosures of cash flow information:
cash paid for interest																											286,000	3,208,000	250,000		258,000	292,000	175,000		165,000	195,000	204,000
cash paid for income taxes																											1,282,000	517,000	121,000		24,000	392,000	51,000		0	956,000	944,000
non-cash investing activities:
purchase of capital equipment by incurring current liabilities																											311,000	958,000	164,000		-183,000	-308,000	760,000	-595,000	-240,000	-497,000	1,504,000	531,000	255,000	15,000	285,000	3,000	1,000	60,000	96,000	32,000	-67,000
reduction of other current liabilities upon issuance of restricted stock units																											0
increase of other current liabilities for purchase of common stock
loss on disposal of assets																																							13,000
purchase of business
proceeds from sale of fixed assets																																						7,000	0
payment of note payable to state agency																																									-1,498,000
other																																						0					-138,000	-83,000	-208,000	-693,000	-635,000	234,000	-302,000
payment on line of credit
impairment of intangible assets
change in fair value of acquisition contingency
accrued royalties																																		40,000	-24,000	-45,000	36,000	23,000	-162,000	-3,000	17,000	-140,000	-1,323,000	-2,736,000	2,201,000	362,000	250,000	-690,000	-3,437,000	861,000	2,657,000
accrued income taxes payable																																		-88,000	368,000	-6,331,000	2,528,000	135,000						-100,000	-8,000	-758,000	758,000	0	-6,151,000
aquisition of biohelix, net of cash acquired
aquisition of andiatec
aquisition of intangibles
payment on acquisition contingency
supplemental disclosures of cash flow information
cash paid during the period for interest																																							286,000	292,000	407,000		485,000	499,000	655,000		644,000	612,000	399,000		148,000	193,000	181,000		188	191	194		201	203	207
cash paid during the period for income taxes																																											80,000				452,000	0	6,500,000		0	6,000	182,000
non-cash investing activities
purchase of licensed technology by incurring current liabilities																																										-1,734,000
lease incentive for tenant improvements
non-cash financing activities
decrease of accrued payroll and related expenses upon issuance of common stock
decrease of other non-current assets upon issuance of common stock
proceeds from the sale of fixed assets																																									115,000
increase of other non-current assets upon issuance of common stock
income tax payable
income tax receivable																																						136,000	0	0	31,000	-90,000	420,000	7,840,000	7,000	-2,890,000	-2,146,000
impairment of long-lived and intangible assets
loss on disposal of property, plant and equipment																																																					6,000
purchase of business, net of cash acquired of - for 2012 and 3,150 for 2010
borrowing from line of credit																																														0	0	0	75,000,000
payments on note payable to state agency																																						0	0
cash and cash equivalents at beginning of year
cash and cash equivalents at end of year
reduction of other non-current assets upon issuance of common stock
prepaid expenses and other current assets																																							-1,847,000				-694,000	194,000	-477,000	933,000	-353,000	928,000	-818,000	-475,000	-193,000
acquisitions of intangibles																																							-194,000
purchases of common stock																																							-20,000			-1,000	0	-339,000	-286,000		0
issuance of common stock, net of cancellations																																							1,599,000	90,000	1,271,000		453,000
acquisition of other non-current assets upon issuance of common stock
purchase of business, net of cash acquired of 3,150
gain on sale of assets																																											6,000			7,000	0
payment for licensed technology
other assets																																											-72,000	17,000	-45,000	16,000	290,000	86,000	-311,000	-19,000	-53,000			307,868	26	52	54
purchase of business, net of cash acquired of 3.1 million																																														20,000	-69,000
purchase of business, net of cash acquired of 3.0 million																																																	-128,201,000
payments on borrowing from line of credit																																													-30,000,000	0
purchase of common stock																																																	-4,676,000	-13,970,000	0
fees paid to establish line of credit
purchase of license agreements by incurring current liabilities
deferred tax asset																																															6,212,000	-5,658,000	-1,501,000	429,000	3,584,000
acquisition of property and equipment																																																	-978,000	-3,670,000	-1,591,000
payments on capital lease obligation																																																			-219,000
depreciation and amortization																																																				2,437,000	2,618,000	9,102,854	1,924	2,210	2,012
deferred income taxes																																																				-1,204,000	3,145,000
other accrued liabilities																																																					216,000
acquisition of property, plant and equipment
payments to acquire common stock
proceeds from issuance of stock under stock plans																																																				961,000	326,000		1,942	73	325
effect of exchange rate changes on cash and cash equivalents																																																							3	15	4
net earnings																																																						21,714,578	2,143
adjustments to reconcile net earnings to net cash from operating activities:
(gain) loss on discontinued operations
foreign currency translation
change in deferred tax asset
excess tax benefit from share based compensation
deferred rent
deferred revenue
other current liabilities
net cash from continuing operations																																																									5,776				7,871
net cash used by discontinued operations
acquisition of plant and equipment
net increase in intangible assets
payments on debt and obligations under capital leases
income from discontinued operations
earnings from continuing operations																																																							2,143	-4,049	5,328
adjustments to reconcile net earnings to net cash from (used by) operating activities:
loss on disposal of property plant and equipment
net cash from (used by) continuing operations																																																							-1,077				1,648
net cash from discontinued operations
net cash from (used by) operating activities																																																							-1,077
acquisition of intangible assets
payments on capital lease obligations
payments to repurchase common stock
net cash from (used by) financing activities
accrued patent litigation
adjustments to reconcile earnings from continuing operations to net cash from operating activities:
compensation expense on stock awards
increase in intangible assets
payments on obligations under capital leases
net proceeds from issuance of common stock and warrants																																																											2,424	1,528	368
net cash from (used by) discontinued operations

We provide you with 20 years of cash flow statements for Quidel stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Quidel stock. Explore the full financial landscape of Quidel stock with our expertly curated income statements.

The information provided in this report about Quidel stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.